SOVREMENNAYA PEDIATRIYA. 2014. 7(63):85–88; doi 10.15574/SP.2014. 

Хвороба Ебола (лекція) 

Чернишова Л. І.

Наведено сучасні відомості про хворобу Ебола, її етіологію, патогенез, шляхи профілактики і лікування. 

Ключові слова: вірус Ебола, лікування, профілактика. 

ЛІТЕРАТУРА

1. Ansari A. A. Clinical features and pathobiology of Ebolavirus infection / A. A. Ansari // J. Autoimmun. — 2014. — Vol. 23. Doi: 10.1016/_j.jaut/2014.09.001. [Epub ahead of print]

2. Caring for critically ill patients with ebola virus disease. Perspectives fr om west Africa / Fowler R. A., Fletcher T., Fischer W. A. [et al.] // Am. J. Respir Crit Care Med. — 2014. — Vol. 190 (7). — P. 733—7.

3. Clark D. V. Clinical management of filovirus-infected patients / D. V. Clark, P. B. Jahrling, J. V. Lawler // Viruses. — 2012. — Vol. 4. — P. 1668—1686.

4. Clinical management of patients with viral haemorrhagic fever: a pocket guide for the front_line health worker / World Health Organization. — World Health Organization, 2014.

5. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit / Barr J., Fraser G. L., Puntillo K. [et al.] // Crit Care Med. — 2013. — Vol. 41. — P. 263.

6. Ebola (Ebola Virus Disease). Centers for Disease Control and Prevention website [Electronic resource]. — Access mode : http://www.cdc.gov/vhf/ebola/. Updated October 3, 2014. Accessed October 16, 2014.

7. Ebola Clinical Care Guidelines: a guide for clinicians in Canada [Electronic resource]. Access mode: http://www.ammi.ca/media/69846/Ebola%20Clinical%20Care%20Guidelines%202%20Sep%202014.pdf. Updated August 29, 2014. Accessed October 16, 2014.

8. Ebola virus disease: potential use of melatonin as treatment / Tan D. X., Korkmaz A., Reiter R. G., Manchester L. C. // J. Pineal. Res. — 2014. — Vol. 27. doi: 10.1111/jpi.12186. [Epub ahead of print]

9. Feldmann H.Ebola haemorrhagic fever / H. Feldmann, T. W. Geisbert //The Lancet. — 2011. — Vol. 377 (9768). — P. 849—62.

10. Filovirus hemorrhagic fever outbreak case management: a review of current and future treatment options / Roddy P., Colebunders R., Jeffs B. [et al.] // Infect Disease. — 2011. — Vol. 204. — P. 791—795.

11. Kortepeter M. G. Basic clinical and laboratory features of filoviral hemorrhagic fever / M. G. Kortepeter, D. G. Bausch, M. Bray // Infect. Disease. — 2011. — Vol. 204. — P. 810—816.

12. Real-time monitoring of cardiovascular function in rhesus macaques infected with Zaire ebolavirus / Kortepeter M. G., Salwer J. V., Hensley L. E. [et al.] // J. Infect Dis. — 2011. — Vol. 204, Suppl 3. — P. 1000—10.

13. Sprecher A. Filovirus haemorrhagic fever guidelines / A. Sprecher. — M-decins Sans Fronti-res Belgium, 2013. (in draft)

14. Treatment of ebola hemorrhagic fever with blood transfusion from convalescent patients / Mupapa K., Massamba M., Kibadi K. [et al.] // J. Infect Dis. — 1999. — Vol. 179 (Suppl. 1). — P. 18—23.

15. WHO finds 70 percent Ebola mortality rate. Aljazeera.com Aljazeera America, 15 Oct 2014. Web. 16 Oct 2014.

16. WHO: IMAI District Clinician Manual: Hospital Care for Adolescents and Adults— Guidelines for the Management of Common Illnesses with Lim ited Resources, 2011. [Electronic resource]. — Access m o d e : http://apps.who.int/iris/bitstre am/10665/77751/1/9789241548281_Vol1_eng.pdf.